Assessment of Neutrophil/Lymphocyte Ratio in Patients with Age-related Macular Degeneration
dc.contributor.author | Ilhan, Nilufer | |
dc.contributor.author | Daglioglu, Mutlu Cihan | |
dc.contributor.author | Ilhan, Ozgur | |
dc.contributor.author | Coskun, Mesut | |
dc.contributor.author | Tuzcu, Esra Ayhan | |
dc.contributor.author | Kahraman, Hilal | |
dc.contributor.author | Keskin, Ugurcan | |
dc.date.accessioned | 2024-09-18T19:52:30Z | |
dc.date.available | 2024-09-18T19:52:30Z | |
dc.date.issued | 2015 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | Purpose: To investigate the neutrophil/lymphocyte ratio (NLR) as an indicator of inflammation in patients with age-related macular degeneration (AMD). Methods: Patients were evaluated by a review of records. The study included 81 patients with dry AMD (group 1), 84 patients with wet AMD (group 2), and 80 healthy age-and sex-matched controls (group 3). The NLR of the patients was obtained from the hospital laboratory archive and was measured by dividing the neutrophil count by the lymphocyte count. Results: A significant difference was found in NLR values between groups 1 and 2 (p = 0.017), groups 2 and 3 (p<0.001), and groups 1 and 3 (p<0.001). In correlation analyses, NLR was correlated positively with age (r = 0.22, p<0.001) and disease severity (r = 0.40, p<0.001). Conclusions: Patients with AMD have higher NLR compared with controls, and NLR correlates with disease severity. NLR may be used as a biomarker of inflammation in AMD. | en_US |
dc.identifier.doi | 10.3109/09273948.2014.921715 | |
dc.identifier.endpage | 290 | en_US |
dc.identifier.issn | 0927-3948 | |
dc.identifier.issn | 1744-5078 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 24987927 | en_US |
dc.identifier.scopus | 2-s2.0-84939429475 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 287 | en_US |
dc.identifier.uri | https://doi.org/10.3109/09273948.2014.921715 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/7463 | |
dc.identifier.volume | 23 | en_US |
dc.identifier.wos | WOS:000361333100005 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Inc | en_US |
dc.relation.ispartof | Ocular Immunology and Inflammation | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Age-related macular degeneration | en_US |
dc.subject | blindness | en_US |
dc.subject | inflammation | en_US |
dc.subject | neutrophil/lymphocyte ratio | en_US |
dc.subject | retinal drusen | en_US |
dc.title | Assessment of Neutrophil/Lymphocyte Ratio in Patients with Age-related Macular Degeneration | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
[ N/A ]
- İsim:
- 7463.pdf
- Boyut:
- 117.63 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text